Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 218 participants.

Also called NCT01240759

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 218 participants (enrolled count) (from the registry)
Sponsor
  • Shionogi Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01240759
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01240759. Randomized; double masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2011-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
S-707106 Dose A
Intervention (Drug)
S-707106 Dose B
Intervention (Drug)
S-707106 Dose C
Intervention (Drug)
Placebo A tablet
Intervention (Drug)
Metformin
Lead sponsor
Shionogi (class: industry)

Record details

Record id
cardio:ct-nct01240759
Content hash
be5de1151f1dd90956c1728fd37caa18a77dc91cc3e537cb54b733045c1a2e95